{
  "id": "cd3a0fcc0317a3af",
  "title": "NovaDerm and Solidaris Capital : How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse",
  "description": "20260127T224500Z",
  "content": "",
  "source": "ibtimes.com",
  "source_url": "https://www.ibtimes.com/novaderm-solidaris-capital-how-selective-narratives-obscure-regulatory-evasion-charitable-tax-3796347",
  "published_at": "20260127T224500Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "regulatory"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.ibtimes.com/novaderm-solidaris-capital-how-selective-narratives-obscure-regulatory-evasion-charitable-tax-3796347",
    "url_mobile": "",
    "title": "NovaDerm and Solidaris Capital : How Selective Narratives Obscure Regulatory Evasion and Charitable Tax Misuse",
    "seendate": "20260127T224500Z",
    "socialimage": "https://d.ibtimes.com/en/full/4641846/novaderm.jpg",
    "domain": "ibtimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}